USD 3.32
(-7.78%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.03 Billion USD | -41.64% |
2022 | 3.47 Billion USD | 136.19% |
2021 | 1.47 Billion USD | 118.76% |
2020 | 672.88 Million USD | 45.56% |
2019 | 462.26 Million USD | 64.49% |
2018 | 281.02 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 346.45 Million USD | -31.45% |
2024 Q2 | 356.24 Million USD | 2.83% |
2023 Q3 | 482.06 Million USD | -6.14% |
2023 Q2 | 513.62 Million USD | -2.68% |
2023 FY | 2.02 Billion USD | -41.64% |
2023 Q1 | 527.77 Million USD | -41.28% |
2023 Q4 | 505.43 Million USD | 4.85% |
2022 Q3 | 856.81 Million USD | 1.19% |
2022 Q2 | 846.7 Million USD | -3.17% |
2022 Q1 | 874.37 Million USD | 102.39% |
2022 Q4 | 898.79 Million USD | 4.9% |
2022 FY | 3.47 Billion USD | 136.19% |
2021 Q1 | 200.32 Million USD | 20.51% |
2021 FY | 1.47 Billion USD | 118.76% |
2021 Q4 | 432.03 Million USD | 1.14% |
2021 Q3 | 427.16 Million USD | 3.56% |
2021 Q2 | 412.47 Million USD | 105.9% |
2020 Q3 | 169.06 Million USD | -1.75% |
2020 Q2 | 172.08 Million USD | 3.97% |
2020 Q1 | 165.5 Million USD | 64.6% |
2020 FY | 672.88 Million USD | 45.56% |
2020 Q4 | 166.23 Million USD | -1.68% |
2019 Q2 | 117.9 Million USD | 0.0% |
2019 Q4 | 100.54 Million USD | -15.07% |
2019 Q3 | 118.38 Million USD | 0.41% |
2019 Q1 | 117.9 Million USD | 0.0% |
2019 FY | 462.26 Million USD | 64.49% |
2018 FY | 281.02 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Alignment Healthcare, Inc. | 1.82 Billion USD | -11.52% |
Marpai, Inc. | 37.15 Million USD | -5373.603% |
NewGenIvf Group Limited | 5.13 Million USD | -39496.172% |